Invention Grant
- Patent Title: In vivo studies of crystalline forms of meloxicam
-
Application No.: US13399730Application Date: 2012-02-17
-
Publication No.: US08389512B2Publication Date: 2013-03-05
- Inventor: Mazen Hanna , Ning Shan , Miranda L. Cheney , David R. Weyna
- Applicant: Mazen Hanna , Ning Shan , Miranda L. Cheney , David R. Weyna
- Applicant Address: US PA Pittsburgh
- Assignee: Thar Pharmaceuticals
- Current Assignee: Thar Pharmaceuticals
- Current Assignee Address: US PA Pittsburgh
- Agency: Rakoczy Molino Mazzochi & Siwik
- Agent Dawn Gardner Krosnick
- Main IPC: C07D279/02
- IPC: C07D279/02 ; C07D417/12 ; A61K31/5415
Abstract:
The invention is directed to novel crystalline forms of meloxicam. These novel crystalline forms of meloxicam have improved bioavailability, an enhanced rate of dissolution and shorter time to Cmax in blood, as compared to pure meloxicam.
Public/Granted literature
- US20120149692A1 In Vivo Studies of Crystalline Forms of Meloxicam Public/Granted day:2012-06-14
Information query
